Abstract

Ethnopharmacological relevanceIH-901 (20-O-beta-d-glucopyranosyl-20(S)-protopanaxadiol) is a novel ginseng saponin metabolite formed by human intestinal bacteria and is known to have antitumor and antimetastatic effects. However, there has been no pharmacokinetic study of IH-901 in human beings. Aim of the studyThe aim of this study was to investigate the pharmacokinetic differences of IH-901 from fermented and non-fermented ginseng. Materials and methodsTo investigate whether the pharmacokinetics of IH-901 differ between fermented and non-fermented ginseng, an open label, randomized, single dose, fasting, two-period, cross-over, pharmacokinetic study was conducted. A total of 24 healthy Korean male volunteers participated in this study. All subjects were allocated into two equal groups and administered 3g of fermented or non-fermented Panax ginseng. Serial blood samples for pharmacokinetic analysis were collected in the 24h after dosing. Plasma IH-901 concentration was measured by a validated high-performance liquid chromatography–tandem mass spectrometry (LC–MS/MS) method. Pharmacokinetic parameters including AUCt, Cmax, and Tmax were calculated by noncompartmental models in the BA-CALC program (KFDA, 2008, 1.0.0, Korea). ResultsAfter oral administration of fermented ginseng, 5 subjects experienced diarrhea. The means of AUCt and Cmax were significantly different between the two groups. In the fermented ginseng group, AUCt was 2083.09±91.97ngh/mL, a 15.5-fold increase over that of IH-901 from the non-fermented group (134.50±63.10ngh/mL), and the mean Cmax was 325.00±91.97ng/mL in the fermented ginseng group, a 27-fold higher value than that in the non-fermented group (13.88±7.24ng/mL). Tmax was 3.29±1.00 and 12.04±4.96h in the fermented and non-fermented group, respectively. ConclusionsThe results of this study showed that the pharmacokinetic parameters of IH-901 from fermented Panax ginseng are different from those of non-fermented ginseng, from which IH-901 is formed by intestinal fermentation.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.